This website is intended for healthcare professionals only.

Newsletter          
Hospital Healthcare Europe
HOPE LOGO
Hospital Healthcare Europe

Key Commentary

Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain
Fluid management in sepsis
Fluid management in sepsis
20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)
20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)
Long intravascular persistence of 20% albumin in postoperative patients
Long intravascular persistence of 20% albumin in postoperative patients
Association between albumin administration and survival in cardiac surgery: a retrospective cohort study
Association between albumin administration and survival in cardiac surgery: a retrospective cohort study
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
Small volume resuscitation with 20% albumin in intensive care: physiological effects: The SWIPE randomised clinical trial
Small volume resuscitation with 20% albumin in intensive care: physiological effects: The SWIPE randomised clinical trial
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites
Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites
Comment: Long-term albumin in cirrhosis: is it the ANSWER?
Comment: Long-term albumin in cirrhosis: is it the ANSWER?
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Popular articles

RP2 oncolytic HSV therapy shows promise in advanced cancer
Semaglutide significantly reduces risk of type 2 diabetes in obese patients
Inspiratory muscle strength training lowers blood pressure
Risk of type 1 diabetes increased after COVID-19 in children and adolescents
Tofersen reduces levels of mutant protein in patients with ALS




 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2022
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora